Comparison of the anti-diabetic effects of resveratrol, gliclazide and losartan in streptozotocin-induced experimental diabetes

References

• Aksoy DY, Gürlek A. (2004). Tip 2 diyabetin tedavisinde yeni umut: thiazolidinedionlar. Hacettepe Tıp Dergisi, 35:123–6
   Google Scholar
• American Diabetes Association. (2013). Diagnosis and classification of diabetes mellitus. Diabetes care, 36(Suppl 1):S67–74
   PubMed Web of Science ®Google Scholar
• Baur JA, Pearson KJ, Price NL, et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444(7117): 337–42
   PubMed Web of Science ®Google Scholar
• Belviranlı M, Gökbel H, Okudan N, Büyükbas S. (2012). Oxidative stress and anti-oxidant status in diabetic rat liver: Effect of plant polyphenols. Arch Physiol Biochem, 118(5):237–43
   PubMed Web of Science ®Google Scholar
• Chi T-C, Chen W-P, Chi T-L, et al. (2007). Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. Life Sci, 80(18):1713–20
   PubMed Web of Science ®Google Scholar
• Collier JJ, Scott DK. (2004). Sweet changes: glucose homeostasis can be altered by manipulating genes controlling hepatic glucose metabolism. Molec Endocrin, 18(5):1051–63
   PubMed Web of Science ®Google Scholar
• Das DK, Maulik N. (2006). Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Molec Interven, 6(1):36–47
   PubMed Web of Science ®Google Scholar
• Gencoglu H, Tuzcu M, Hayirli A, Sahin K. (2015). Protective effects of resveratrol against streptozotocin-induced diabetes in rats by modulation of visfatin/sirtuin-1 pathway and glucose transporters. Int J Food Sci Nutr, 66(3):314–20
   PubMed Web of Science ®Google Scholar
• Groop L, Pociot F. (2014). Genetics of diabetes – are we missing the genes or the disease? Molec Cell Endocrin, 382(1):726–39
   PubMed Web of Science ®Google Scholar
• Hausenblas HA, Schoulda JA, Smoliga JM. (2015). Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus—systematic review and meta-analysis. Molec Nutr Food Res, 59(1):147–59
   PubMed Web of Science ®Google Scholar
• Lee DH, Park K-S, Kim D-R, et al. (2008). Dual effect of ATP on glucose-induced insulin secretion in HIT-T15 cells. Pancreas, 37(3):302–8
   PubMed Web of Science ®Google Scholar
• Masiello P, Broca C, Gross R, et al. (1998). Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes, 47(2):224–9
   PubMed Web of Science ®Google Scholar
• Moynihan KA, Grimm AA, Plueger MM, et al. (2005). Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice. Cell Metab, 2(2):105–17
   PubMed Web of Science ®Google Scholar
• Nishi EE, Bergamaschi CT, Oliveira-Sales EB, et al. (2013). Losartan reduces oxidative stress within the rostral ventrolateral medulla of rats with renovascular hypertension. Am J Hypertension, 26(7):858–65
   PubMed Web of Science ®Google Scholar
• Nurjhan N, Consoli A, Gerich J. (1992). Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest, 89(1):169–175
   PubMed Web of Science ®Google Scholar
• Palsamy P, Subramanian S. (2008). Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed Pharma, 62(9):598–605
   PubMed Web of Science ®Google Scholar
• Penumathsa SV, Thirunavukkarasu M, Koneru S, et al. (2007). Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Molec Cell Cardiol, 42(3):508–16
   PubMed Web of Science ®Google Scholar
• Pulido N, Suarez A, Casanova B, et al. (1997). Gliclazide treatment of streptozotocin diabetic rats restores GLUT4 protein content and basal glucose uptake in skeletal muscle. Metab, 46:10–13
   PubMed Web of Science ®Google Scholar
• Rakieten N, Rakieten M, Nadkarni M. (1963). Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemo Reports Part 1, 29:91–8
   PubMedGoogle Scholar
• Roberts D, Miyamoto S. (2015). Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy. Cell Death Diff, 22(2):248–57
   PubMed Web of Science ®Google Scholar
• Sharma N, Rao SS, Kumar ND, et al. (2011). A validated stability-indicating liquid-chromatographic method for ranitidine hydrochloride in liquid oral dosage form. Scientia Pharmaceutica, 79(2):309–22
   PubMedGoogle Scholar
• Soleas GJ, Diamandis EP, Goldberg DM. (2001). The world of resveratrol. Adv Exp Med Biol, 492:159–82
   PubMed Web of Science ®Google Scholar
• Tian W-N, Braunstein LD, Pang J, et al. (1998). Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J Biol Chem, 273(17):10609–17
   PubMed Web of Science ®Google Scholar
• Tian W-N, Braunstein LD, Apse K, et al. (1999). Importance of glucose-6-phosphate dehydrogenase activity in cell death. Am J Physiol-Cell Physiol, 276(5):C1121–31
   Web of Science ®Google Scholar
• Xu Y, Osborne BW, Stanton RC. (2005). Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol-Renal Physiol, 289(5):F1040–7
   PubMed Web of Science ®Google Scholar